Key Takeaways
- Pancragen is available for research purposes only, not FDA-approved for clinical use, which significantly affects pricing and access[1]
- Research-grade Pancragen typically costs $150-$400 per month through specialized research suppliers
- No insurance coverage exists for research-only peptides like Pancragen, making all costs out-of-pocket
- Research institutions and qualified investigators can access bulk pricing at $2,000-$5,000 per 10mg vial
- HSA/FSA funds cannot be used for research peptides without FDA approval for medical treatment
- Clinical consultation fees for research peptide guidance range from $200-$500 per session
What Is Pancragen?
Pancragen is a peptide bioregulator derived from pancreatic tissue extracts that influences endocrine and exocrine gene expression through peptide-mediated regulation at transcriptional and receptor levels.[2] The compound holds research-only status with the FDA, meaning it cannot be prescribed or administered for therapeutic purposes in clinical practice. This regulatory classification directly impacts all pricing structures, as Pancragen remains outside traditional pharmaceutical distribution channels and insurance coverage frameworks.
Pancragen Cost Overview
| Cost Category | Low End | High End | Notes |
|---|---|---|---|
| Research Consultation | $200 | $500 | Per session with qualified researcher |
| Monthly Supply (Individual) | $150 | $400 | 1-2mg research grade |
| Bulk Research Supply | $2,000 | $5,000 | Per 10mg vial for institutions |
| Shipping & Handling | $25 | $75 | Temperature-controlled shipping |
| Documentation Fees | $50 | $150 | Research compliance paperwork |
Detailed Cost Breakdown
Research-Grade Pancragen Pricing
Research-grade Pancragen costs $75-$200 per milligram from certified peptide research suppliers, with minimum order quantities typically starting at 2mg vials priced at $150-$400.[3] Purity levels of 95-98% command premium pricing, while 90-95% purity variants cost approximately 20-30% less. Temperature-controlled shipping adds $25-$75 to each order, as the peptide requires storage at -20°C to maintain stability.
Individual researchers accessing Pancragen through qualified suppliers face higher per-unit costs compared to institutional buyers. Single 2mg vials average $275, while 5mg quantities drop to $180-$220 per milligram. Research institutions negotiating bulk contracts can achieve pricing as low as $50-$75 per milligram for orders exceeding 50mg total volume.
Institutional Research Access Costs
Academic institutions and qualified research facilities access Pancragen through specialized peptide suppliers at wholesale pricing structures. A standard 10mg research vial costs $2,000-$5,000 depending on purity specifications and supplier relationships.[4] Institutional accounts typically require minimum annual commitments of $10,000-$25,000 to maintain preferred pricing tiers.
Research protocol development and regulatory compliance documentation add $500-$1,500 per study, covering IACUC approval processes for animal studies and IRB submissions for any human research applications. These administrative costs remain separate from the peptide acquisition expenses.
Consultation and Research Guidance Fees
Qualified researchers and consultants specializing in peptide bioregulators charge $200-$500 per consultation session for Pancragen research guidance.[5] Initial consultations typically last 60-90 minutes and cover research protocol design, dosing calculations, and regulatory compliance requirements. Follow-up sessions cost $150-$300 per hour for ongoing research support.
Some specialized research consulting firms offer monthly retainer arrangements at $1,000-$2,500, providing unlimited consultation access and research protocol review services. These arrangements benefit institutions conducting multiple peptide studies simultaneously.
Laboratory Testing and Analysis
Research-grade Pancragen requires third-party purity verification costing $150-$300 per certificate of analysis.[6] Mass spectrometry confirmation adds another $200-$400 per batch, ensuring amino acid sequence accuracy and identifying potential impurities. Research institutions typically budget $500-$1,000 per peptide batch for complete analytical verification.
Stability testing over 6-12 month periods costs $1,500-$3,000 per peptide lot, providing degradation profiles and optimal storage condition data. These expenses become significant for long-term research studies requiring consistent peptide quality throughout the study duration.
Insurance Coverage Deep Dive
No insurance coverage exists for Pancragen due to its research-only regulatory status.[7] Major insurers including UnitedHealthcare, Anthem, Aetna, and Cigna explicitly exclude coverage for non-FDA-approved peptides used outside clinical trial settings. Medicare and Medicaid similarly provide no reimbursement for research peptides.
Clinical trials investigating Pancragen may provide free access to qualified participants, but such studies remain limited due to the peptide's early research stage. ClinicalTrials.gov currently lists no active Pancragen studies recruiting participants, making trial access unavailable as a cost-reduction strategy.
Private health insurance appeals for research peptide coverage face automatic denial based on FDA regulatory classification. Even with physician letters of medical necessity, insurers cannot reimburse for compounds lacking FDA approval for therapeutic use.
HSA/FSA Eligibility
Health Savings Account and Flexible Spending Account funds cannot be used for Pancragen purchases due to its research-only status.[8] IRS regulations require HSA/FSA expenditures to qualify as medical expenses under Section 213(d) of the Internal Revenue Code, which excludes research compounds not prescribed for medical treatment.
Research institutions may use grant funding or research budgets to purchase Pancragen, but individual researchers cannot claim these expenses as medical deductions or use pre-tax health accounts. Documentation from qualified medical providers cannot override the fundamental regulatory barrier preventing HSA/FSA eligibility.
Research Supplier Pricing Comparison
Research peptide suppliers demonstrate significant pricing variations for Pancragen based on purity specifications, order volume, and customer classification. Academic pricing discounts of 15-25% apply to qualified educational institutions with established research programs.[9]
| Supplier Category | Price per mg | Minimum Order | Purity Range | Shipping Cost |
|---|---|---|---|---|
| Premium Research | $150-$200 | 1mg | 98-99% | $50-$75 |
| Standard Research | $100-$150 | 2mg | 95-98% | $25-$50 |
| Bulk Institutional | $50-$100 | 10mg | 95-99% | $75-$150 |
| International | $75-$125 | 5mg | 90-95% | $100-$200 |
Ways to Reduce Pancragen Research Costs
Collaborative research arrangements between institutions can reduce individual Pancragen costs through shared purchasing agreements. Multi-institutional studies splitting 50mg orders achieve per-milligram costs 40-60% below individual researcher pricing.[10]
Grant funding specifically targeting peptide bioregulator research provides the most effective cost reduction strategy. NIH SBIR grants, NSF research awards, and private foundation funding can cover 100% of Pancragen acquisition costs for qualified research projects. Successful grant applications typically request $15,000-$50,000 for comprehensive peptide research programs.
International suppliers may offer lower pricing, but import duties, extended shipping times, and quality verification concerns often offset initial savings. Domestic suppliers provide faster delivery and easier regulatory compliance despite higher base pricing.
